Welireg

(belzutifan)
belzutifan 40 MG Oral Tablet [Welireg]

Dosage & administration

The recommended dosage of WELIREG is 120 mg administered orally once daily with or without food.

Most viewed Welireg resources

Enroll in Patient Savings Program

drug label

Welireg prescribing information

Have more Welireg questions?

Submit MSL Request
Learn More

Need to report a Welireg issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Welireg samples

NOT PROVIDED BY BRAND
View Online Sample Form
Learn More

prior authorization

Welireg Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

Welireg Merck Access Program Application
Welireg Merck Access Program Application - Online Portal
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Welireg Financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Welireg Merck Access Program Application
Welireg Merck Access Program Application - Online Portal
Learn More

patient education

Welireg Patient education

Getting started on Welireg

NOT PROVIDED BY BRAND
Instructions For Use - von Hippel-Lindau (VHL) disease

Patient toolkit

About Welireg
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.